Major Players in the Romania Donepezil Market | Competitive Landscape 2026

Major Players in the Romania Donepezil Market

The Romania Donepezil Market is driven by a combination of major domestic drug manufacturers and global giants, with a focus on Central Nervous System (CNS) health, providing essential acetylcholinesterase inhibitors for the treatment of cognitive impairment and Alzheimer’s dementia. The key players in the market are Terapia (Sun Pharma), Antibiotice Iași, Zentiva Romania, Krka, Sandoz, Teva Pharmaceutical, Pfizer, Viatris, Gedeon Richter, and Egis Pharmaceuticals.

Romania Donepezil Market Overview

According to 6Wresearch, the Romania Donepezil Market is expected to grow with changing healthcare trends, owing to a growing geriatric population and increasing focus on geriatric mental health services in national healthcare system. Donepezil is considered as a first line pharmacological treatment for improvement of cognitive function, memory retention and stability of behaviour in Alzheimer type dementia.

The market is driven by the modernization of Romania’s healthcare infrastructure, particularly in the neurodegenerative care sector, with specialized neurology departments and long-term care facilities increasingly incorporating Donepezil into their standard treatment protocols. Production and supply strategies are increasingly focused on high bioavailability oral formulations with consistent availability, to ensure the continued availability of advanced therapeutic options.

Competitive Landscape

The competitive landscape of the Romania Donepezil Industry consists of local manufacturing leaders and well-established international pharmaceutical companies. The leading companies are investing heavily in the drug quality control and regulatory compliance, to ensure that the neurotransmission modulating compounds are reliably effective. Additionally, there is a growing interest in improving patient outcomes by having different generic formulations available and developing comprehensive patient support programs.

Below is a list of leading players operating in the Romania Donepezil Market:

1. Terapia (Sun Pharma)

Terapia leverages its extensive local manufacturing capacity and regional distribution network to provide high-quality CNS medications.

2. Antibiotice Iași

Antibiotice Iași utilizes its significant domestic production heritage to support the local neurodegenerative supply chain with affordable and reliable Donepezil formulations.

3. Zentiva Romania

Zentiva utilizes its strong footprint in the Romanian market and international R&D capabilities to ensure consistent supply and accessibility of essential cognitive enhancers.

4. Krka Novo mesto

Krka focuses on high-purity generic pharmaceutical manufacturing, supporting the Romanian healthcare sector with cost-effective, quality-assured Donepezil solutions.

5. Sandoz (Novartis)

Sandoz leverages its global expertise to provide high-efficacy treatments that meet international safety standards, serving as a key supplier for specialized dementia care.

6. Teva Pharmaceutical Industries Ltd.

Teva provides a wide range of essential neuro-active medications, ensuring broad accessibility across Romania’s regional clinics and hospitals.

7. Pfizer Inc.

Pfizer maintains a focus on life-critical therapeutic areas and supports the healthcare sector with consistent, high-standard supply of cognitive enhancers.

8. Viatris Inc.

Viatris contributes to the neurological health sector through patient-centric formulations and a robust portfolio of specialty drugs for chronic conditions.

9. Gedeon Richter Plc.

Gedeon Richter focuses on consistent pharmaceutical manufacturing and plays a key role in the supply of therapeutic options for the aging geriatric population.

10. Egis Pharmaceuticals PLC

Egis utilizes its advanced manufacturing platforms to support the healthcare sector, ensuring the stable supply of essential CNS therapeutics for aging patients.

Major Players in the Romania Donepezil Market: FAQs